Searched for
CEPHALEXIN
Stocks in news: Angel One, Maruti Suzuki, Dabur, Marico, Aurobindo Pharma, ITCMaruti Suzuki reported a nearly 2% jump in September total sales at 1,84,727 units versus 1,81,343 units in the corresponding month of the ...- Delhi Mohalla Clinic Scam: CBI to investigate 'fake' tests prescribed by mohalla clinicsThe Union Home Ministry has ordered the Central Investigation Agency to investigate allegations of fake diagnostic tests prescribed by Delh...
- CBI to probe supply of 'poor' medicines to Delhi govt hospitalsIn its letter the Delhi government's Director of Vigilance wrote "It also needs to be investigated whether the same drugs which have been p...
- "Will see how far Kejriwal can run...": BJP Delhi chief guns for CM after MHA orders CBI probe into supply of 'sub-standard' drugsThe BJP's Delhi chief, Virendraa Sachdeva, has criticised Chief Minister Arvind Kejriwal for allegedly procuring and supplying spurious and...
- 'Fake' drugs row: Directorate of Vigilance asks health department to withdraw drugs that failed testsThe Directorate of Vigilance of the Delhi government has written to the health department to withdraw the drugs that failed quality standar...
- Ascend Laboratories recalls over 20,000 bottles of antibacterial drug in USThe US-based Ascend Laboratories LLC is recalling 20,232 bottles of Cephalexin for oral suspension, USP, 125 mg per 5 mL, manufactured by A...
- Need no monopoly in healthcare in India: YK Hamied, Chairman, CiplaThe pharma industry is not like cement or sugar where you go on making it year in year out and there is no change. Here the older drugs die...
- Drug companies see no business value in raw material productionSeveral drug makers and trade body representatives want the government to focus on attaining self-sufficiency in producing key raw material...
- India relies on China for 90 per cent of drug raw materialsIndia's acute dependence for key raw materials which are used to make at least 15 essential drugs can affect pharma industry if a situation...
- Sun Pharmaceutical's woes deepen as US arm Taro recalls Warfarin from marketsThis is the third such recall for Sun which agreed to buy troubled fellow drug maker Ranbaxy in March this year to create the world's fifth...
- Sun Pharma unit recalls mutiple lots of capsules from USCaraco Pharmaceutical Laboratories , a unit of Sun Pharma, has initiated a recall of multiple lots of Cephalexin capsules from the US marke...
- JM Financial puts buy on Aurobindo PharmaJM Financial has upgraded Aurobindo Pharma to ‘buy’ with a target price of Rs207 mainly due to attractive valuation post the recent stock c...
- Ranbaxy's Simvastatin to go Down Under by AugRanbaxy Laboratories is planning to launch cardiovascular drug Simvastatin in Australia this year.
- Paswan slashes prices of 886 drugsThe list includes anti-diabetic pills, antibiotics, cough syrups, pain killers and anti-hypertensives.
Load More
